Other
Pre-Tax Income (Domestic)
Insmed Pre-Tax Income (Domestic) remained flat by 0.0% to -$279.62M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 37.3%, from -$203.63M to -$279.62M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income (Domestic) shows a downward trend with a 33.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
First reportedQ1 2013
Last reportedQ4 2025Feb 19, 2026
Metric ID:
other_income_loss_from_continuing_operations_before_inco_5322d6Historical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$348.85M | -$406.26M | -$666.18M | -$814.53M | -$1.12B |
| YoY Change | — | -16.5% | -64.0% | -22.3% | -37.3% |
Range-$1.12B – -$348.85M
CAGR+33.8%
Avg YoY Growth-35.0%
Median YoY Growth-29.8%
Current Streak4+ years decline
Pre-Tax Income (Domestic) at Other Companies
Frequently Asked Questions
- What is Insmed's pre-tax income (domestic)?
- Insmed (INSM) reported pre-tax income (domestic) of -$279.62M in Q4 2025.
- How has Insmed's pre-tax income (domestic) changed year-over-year?
- Insmed's pre-tax income (domestic) decreased by 37.3% year-over-year, from -$203.63M to -$279.62M.
- What is the long-term trend for Insmed's pre-tax income (domestic)?
- Over 4 years (2021 to 2025), Insmed's pre-tax income (domestic) has grown at a 33.8% compound annual growth rate (CAGR), from -$348.85M to -$1.12B.